These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37413872)

  • 1. Evaluating cognitive impairment in the early stages of Parkinson's disease using the Cambridge brain sciences-cognitive platform.
    Hosseini M; Borhani-Haghighi A; Petramfar P; Foroughi AA; Ostovan VR; Nami M
    Clin Neurol Neurosurg; 2023 Sep; 232():107866. PubMed ID: 37413872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mini-mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's disease.
    Caslake R; Summers F; McConachie D; Ferris C; Gordon J; Harris C; Caie L; Counsell C
    Curr Aging Sci; 2013 Dec; 6(3):273-9. PubMed ID: 23773030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.
    Masala C; Solla P; Liscia A; Defazio G; Saba L; Cannas A; Cavazzana A; Hummel T; Haehner A
    J Neurol; 2018 Aug; 265(8):1764-1771. PubMed ID: 29804147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life.
    Lawson RA; Yarnall AJ; Duncan GW; Khoo TK; Breen DP; Barker RA; Collerton D; Taylor JP; Burn DJ
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1071-5. PubMed ID: 25074728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.
    Burdick DJ; Cholerton B; Watson GS; Siderowf A; Trojanowski JQ; Weintraub D; Ritz B; Rhodes SL; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Srivatsal S; Edwards KL; Montine TJ; Zabetian CP; Leverenz JB
    Mov Disord; 2014 Sep; 29(10):1258-64. PubMed ID: 25073717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between olfactory loss and cognitive deficits in Parkinson's disease.
    Camargo CHF; Jobbins VA; Serpa RA; Berbetz FA; Sabatini JS; Teive HAG
    Clin Neurol Neurosurg; 2018 Oct; 173():120-123. PubMed ID: 30121454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.
    Mao CJ; Wang F; Chen JP; Yang YP; Chen J; Huang JY; Liu CF
    Clin Interv Aging; 2017; 12():1637-1644. PubMed ID: 29070942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation of non-motor symptoms and sleep on balance in Parkinson's disease patients with normal cognition and mild cognitive impairment.
    Saricaoglu M; Yilmaz NH; Ozer FF; Hanoglu L
    Ir J Med Sci; 2021 Nov; 190(4):1577-1584. PubMed ID: 33449322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.
    Mamikonyan E; Moberg PJ; Siderowf A; Duda JE; Have TT; Hurtig HI; Stern MB; Weintraub D
    Parkinsonism Relat Disord; 2009 Mar; 15(3):226-31. PubMed ID: 18595765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of cognitive impairment in an early stage Parkinson's disease cohort.
    Hu MT; Szewczyk-Królikowski K; Tomlinson P; Nithi K; Rolinski M; Murray C; Talbot K; Ebmeier KP; Mackay CE; Ben-Shlomo Y
    Mov Disord; 2014 Mar; 29(3):351-9. PubMed ID: 24395708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.
    Kang SH; Lee HM; Seo WK; Kim JH; Koh SB
    J Neurol Sci; 2016 Sep; 368():374-8. PubMed ID: 27538667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.
    Mahmoudi Asl A; Mehdizadeh M; Kulisevsky J; Sabet A; Taghavi Azar Sharabiani P; Mehdizadeh H; Ashayeri H; Taghizadeh G
    Disabil Rehabil; 2022 May; 44(10):2091-2098. PubMed ID: 32924645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
    Athey RJ; Porter RW; Walker RW
    Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MemTrax memory test for detecting and assessing cognitive impairment in Parkinson's disease.
    Liu Y; Wu L; Chen W; Su F; Liu G; Zhou X; Ashford CB; Li F; Ashford JW; Pei Z; Xian W
    Parkinsonism Relat Disord; 2024 Mar; 120():106016. PubMed ID: 38325255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
    PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlations between olfactory and cognitive functions in early stage Parkinson's disease].
    Guo S; Li L; Dai Y; Tang Q; Chen Y; Li S; Chen J; Mao C; Li J; Liu C
    Zhonghua Yi Xue Za Zhi; 2015 Feb; 95(7):489-92. PubMed ID: 25916921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.